Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.

Abstract

COVID-19, the disease caused by SARS-CoV-2, is a highly contagious disease. The World Health Organization has declared the ongoing outbreak to be a global public health emergency. Currently, the research on SARS-CoV-2 is in its primary stages. Based on current published evidence, this review systematically summarizes the epidemiology, clinical characteristics, diagnosis, treatment and prevention of COVID-19. It is hoped that this review will help the public to recognize and deal with SARS-CoV-2, and provide a reference for future studies.

Keywords: COVID-19; Coronavirus; Pneumonia; Respiratory infection; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Betacoronavirus / classification
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / pathology
  • Coronavirus Infections* / therapy
  • Coronavirus Infections* / transmission
  • Genome, Viral / genetics
  • Host Specificity / physiology
  • Humans
  • Immunization, Passive / methods
  • Pandemics* / statistics & numerical data
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / pathology
  • Pneumonia, Viral* / therapy
  • Pneumonia, Viral* / transmission
  • Prevalence
  • SARS-CoV-2

Supplementary concepts

  • COVID-19 serotherapy